Kintara Therapeutics (KTRA) Financials

$0.23

$-7.82 (-97.20%)

As on 17-Oct-2024 19:49EDT

Market cap

$12 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

7.8

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15
Operating Revenue	0.08	--	--	--	--	--
Cost of Revenue	0.06	0.06	0.06	0.06	0.03	0.01
Gross Profit	0.02	-0.06	-0.06	-0.06	-0.03	-0.01
Operating Expenses	7.87	8.45	14.80	22.68	21.57	8.14
Operating Profit (EBIT)	0.75	-8.50	-14.81	-22.69	-21.67	-7.09
Other Income	--	--	--	--	--	--
Profit before Tax	-7.86	-8.50	-14.65	-22.66	-38.30	-9.13
Provision for Tax	0.03	0.08	-0.15	-0.04	0.03	0.98
Profit after Tax (Net Income)	-7.86	-8.50	-14.65	-22.62	-38.32	-10.11
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	-15.02	-25.13	-41.50	-9.13

Liabilities ($ Mln)	TTM	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15
Shareholder's Funds	3.76	3.76	0.73	11.80	10.58	0.26
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.19	0.19	0.17	0.16	0.18	2.01
Current Liabilities	2.26	2.26	3.08	3.99	2.78	2.67
Total Liabilities	8.46	6.20	3.98	15.95	13.54	2.94

Assets ($ Mln)	TTM	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15
Non-Current Assets	0.67	0.67	0.71	2.69	1.75	0.09
Current Assets	5.53	5.53	3.27	13.26	11.79	2.85
Total Assets	11.73	6.20	3.98	15.95	13.54	2.94
Total Debt*	--	--	--	--	--	--
Net Current Assets	--	3.27	0.19	9.27	9.01	0.18

Cashflow ($ Mln)	TTM	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15
Cash From Operating Activities	--	-7.18	-11.87	-20.39	-18.86	-7.93
Cash Flow from Investing Activities	--	--	-0.23	-0.23	0.96	0.96
Cash from Financing Activities	--	10.57	1.85	21.64	26.04	6.60
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15
ROCE (%)	--	-378.83	-233.90	-202.17	-706.81	-906.18
ROE (%)	-162.48	-378.83	-233.90	-202.17	-706.81	-906.18
ROA (%)	-95.06	-167.00	-147.03	-153.40	-465.07	-289.80
EBIT Margin (%)	-7,150.00	--	--	--	--	--
Net Margin (%)	-10,346.05	--	--	--	--	--
Cash Profit Margin (%)	-0.26	--	--	--	--	--

Growth Ratios	TTM	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	58.55	42.88	34.77	40.59	-438.63	18.42
Net Profit Growth (%)	39.20	41.97	35.24	40.98	-279.17	-36.43
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15
Price / Earnings	--	--	--	--	--	--
Price / Book Value	7.81	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.37	0.58	0.10	0.52	0.28	0.34
Close Price ($)	6.83	9.45	141.05	486.50	3,972.50	1,203.65
High Price ($)	160.51	196.00	700.00	4,987.50	5,862.50	4,655.00
Low Price ($)	2.84	2.84	94.50	246.05	1,067.50	665.00
Market Cap ($ Cr)	11.99	--	--	--	--	--

Solvency Ratios	TTM	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15
Debt to Equity	--	--	--	--	--	--
Short term debt to equity ratio	--	--	--	--	--	--
Current Ratio	2.45	2.45	1.06	3.32	4.24	1.07
Quick Ratio	2.45	--	0.93	3.69	4.51	1.03
Interest Coverage	--	--	--	-1,620.14	-1,468.38	--

Operating Efficiency Ratios	TTM	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	0.01	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	2,755.98	-3,235.51	-6,799.74	-3,779.76	3,422.43
Payable days	--	16,572.39	18,423.82	16,704.10	24,141.07	68,586.19
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.